活体肝移植供者远程缺血预处理对供受者术后肝功能的影响:随机临床试验
这项随机临床试验纳入148例活体肝移植供者,随机分为远程缺血预处理(RIPC)组(75例)和对照组(73例)。RIPC未改善供者肝切除术后肝功能,但受者术后第1天及7天内最大AST水平显著低于对照组。受者早期移植物功能不全和移植物衰竭发生率无显著差异。
要点
- RIPC未改善活体肝移植供者术后肝功能。
- 接受预处理供肝的受者术后AST水平显著降低。
- 受者早期移植物功能不全和移植物衰竭无显著差异。
核心结论
- RIPC未改善活体肝切除供者的肝功能,但可能对活体肝移植受者术后肝功能有益。
研究设计与样本
- 随机临床试验,共148例活体肝移植供者随机分为RIPC组(n=75)和对照组(n=73)。
- RIPC方案为对上臂血压袖带充气至200 mm Hg,5分钟充气后5分钟再灌注,共3个循环。
主要发现
- 供者肝切除术后AST和ALT水平在两组间无差异。
- 供者延迟性移植物肝功能发生率RIPC组6.7% vs 对照组0.0%(P=0.074)。
- 受者术后第1天AST水平RIPC组217.0(158.0, 288.0)vs 对照组259.5(182.0, 340.0),P=0.033。
- 受者术后7天内最大AST水平RIPC组244.0(167.0, 334.0)vs 对照组296.0(206.0, 395.5),P=0.029。
- 受者早期移植物功能不全发生率4.1% vs 5.6%(P=0.955),移植物衰竭发生率1.4% vs 5.6%(P=0.346)。
临床怎么用
- 在活体肝移植中,对供者实施RIPC可能有助于改善受者术后早期肝功能,但需权衡其未改善供者肝功能的结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: This study aimed to assess the effects of remote ischemic preconditioning (RIPC) on liver function in donors and recipients after living donor liver transplantation (LDLT). BACKGROUND: Ischemia reperfusion injury (IRI) is known to be associated with graft dysfunction after liver transplantation. RIPC is used to lessen the harmful effects of IRI. METHODS: A total of 148 donors were randomly assigned to RIPC (n = 75) and control (n = 73) groups. RIPC involves 3 cycles of 5-minute inflation of a blood pressure cuff to 200 mm Hg to the upper arm, followed by 5-minute reperfusion with cuff deflation. The primary aim was to assess postoperative liver function in donors and recipients and the incidence of early allograft dysfunction and graft failure in recipients. RESULTS: RIPC was not associated with any differences in postoperative aspartate aminotransferase (AST) and alanine aminotransferase levels after living donor hepatectomy, and it did not decrease the incidence of delayed graft hepatic function (6.7% vs 0.0%, P = 0.074) in donors. AST level on postoperative day 1 [217.0 (158.0, 288.0) vs 259.5 (182.0, 340.0), P = 0.033] and maximal AST level within 7 postoperative days [244.0 (167.0, 334.0) vs 296.0 (206.0, 395.5), P = 0.029) were significantly lower in recipients who received a preconditioned graft. No differences were found in the incidence of early allograft dysfunction (4.1% vs 5.6%, P = 0.955) or graft failure (1.4% vs 5.6%, P = 0.346) among recipients. CONCLUSIONS: RIPC did not improve liver function in living donor hepatectomy. However, RIPC performed in liver donors may be beneficial for postoperative liver function in recipients after living donor liver transplantation.
引用
- Jung KW, Kang J, Kwon HM, et al. Effect of Remote Ischemic Preconditioning Conducted in Living Liver Donors on Postoperative Liver Function in Donors and Recipients Following Liver Transplantation: A Randomized Clinical Trial. Ann Surg. 2020. PMID: 31356262. doi:10.1097/SLA.0000000000003498
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。